GlaxoSmithKline PLC — Director's Dealing 2015

Oct 20, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8505C

GlaxoSmithKline PLC

20 October 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 19 October 2015 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1268.00 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $38.74 per ADS, following the notional re-investment of the dividend paid to shareholders on 1 October 2015.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	20,795.027
Dr M M Slaoui		6,024.851
Mr S Dingemans	9,032.509
Mr R G Connor	4,050.334
Mr N Hirons	649.011	221.244
Mr S A Hussain	8,490.521
Mr D S Redfern	3,080.089
Ms C Thomas	4,280.313
Mr P C Thomson	2,185.682
Mr D E Troy		3,748.095
Dr P J T Vallance	9,114.322
Ms E Walmsley	6,163.729
Mrs V A Whyte	574.634

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (Connected Person to Dr M M Slaoui)		97.460
Mrs K Thomson (Connected Person to Mr P C Thomson)	54.238

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

20 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLBLFLEBFFFBK